Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,112 public trials 3,999 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL

NCT07409428

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
  • Baoding NO.1 Central Hospital Baoding, China
  • Beijing GoBroad Hospital Beijing, China
  • BEIJING TONGREN HOSPITAL, Capital Medical University Beijing, China
View all 50 locations
View Trial Details
Recruiting

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

NCT07155226

Conditions
Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia, Bone Marrow Diseases, +15 more
Locations
  • Research Site Decatur, Illinois, United States
  • Research Site New York, United States
  • Research Site Chapel Hill, North Carolina, United States
  • Research Site Durham, North Carolina, United States
View all 30 locations
View Trial Details
Recruiting

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

NCT07046078

Conditions
Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Bone Marrow Diseases, +22 more
Locations
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Recruiting

Comprehensive HHT Outcomes Registry of the United States (CHORUS)

NCT06259292

Conditions
Arteriovenous Malformations, Brain Diseases, Cardiovascular Abnormalities, +35 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Colorado, Denver Aurora, Colorado, United States
View all 16 locations
View Trial Details
Recruiting

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

NCT05429632

Conditions
Adult Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Alabama Hospital (UAB Hospital) Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Comprehensive Cancer Center - Duarte Duarte, California, United States
  • University of California Los Angeles (UCLA) - David Geffen School of Medicine Los Angeles, California, United States
View all 111 locations
View Trial Details

Related conditions